| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 54.54B | 12.96B | 11.07B | 10.19B | 9.29B |
| Gross Profit | 54.54B | 12.59B | 10.72B | 9.90B | 8.99B |
| EBITDA | 1.11B | 704.00M | 423.00M | 1.26B | 2.92B |
| Net Income | 498.00M | 191.00M | 457.00M | 783.00M | 2.05B |
Balance Sheet | |||||
| Total Assets | 582.27B | 544.17B | 522.10B | 506.32B | 575.46B |
| Cash, Cash Equivalents and Short-Term Investments | 17.10B | 18.58B | 22.54B | 36.26B | 16.49B |
| Total Debt | 25.11B | 7.70B | 6.12B | 5.48B | 5.39B |
| Total Liabilities | 579.96B | 540.66B | 517.31B | 494.18B | 564.51B |
| Stockholders Equity | 2.28B | 3.55B | 4.83B | 5.56B | 10.98B |
Cash Flow | |||||
| Free Cash Flow | 4.50B | -4.54B | -14.48B | 20.28B | -374.00M |
| Operating Cash Flow | 4.55B | -4.45B | -14.24B | 20.46B | -169.00M |
| Investing Cash Flow | 170.00M | 239.00M | -422.00M | -226.00M | 133.00M |
| Financing Cash Flow | -2.93B | 331.00M | -556.00M | -1.03B | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £3.42B | 6.07 | 6.50% | 7.21% | -7.11% | 0.45% | |
76 Outperform | £8.90B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
74 Outperform | £2.37B | 8.36 | -0.05% | 3.40% | -28.04% | -102.43% | |
70 Outperform | £2.12B | 17.89 | 4.75% | 4.91% | 14.05% | -3.07% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
52 Neutral | £6.66B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% | |
48 Neutral | £13.65B | 30.04 | 6.81% | 8.29% | -38.98% | -31.14% |